Golden House Ltd (TLV:GOHO)
1,063.00
+22.00 (2.11%)
Jul 3, 2026, 1:44 PM IDT
Golden House Market Cap
Golden House has a market cap or net worth of 164.94 million as of July 2, 2026. Its market cap has decreased by -18.48% in one year.
Market Cap
164.94M
Enterprise Value
123.97M
Revenue
46.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,063.00
Market Cap Chart
Since March 30, 2006, Golden House's market cap has increased from 74.77M to 164.94M, an increase of 120.60%. That is a compound annual growth rate of 3.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 164.94M | 4.01% |
| Dec 31, 2025 | 158.58M | -55.97% |
| Dec 31, 2024 | 360.14M | 47.35% |
| Dec 31, 2023 | 244.41M | 50.96% |
| Dec 29, 2022 | 161.90M | -36.51% |
| Dec 30, 2021 | 255.00M | 16.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 116.13B |
| Danel (Adir Yeoshua) | 2.74B |
| Amal Holdings A.D. | 2.37B |
| BrainsWay | 1.84B |
| Geffen Residence & Renewal | 304.01M |
| InterCure | 185.32M |
| Epitomee Medical | 154.85M |
| Rekah Pharmaceutical Industry | 124.88M |